See How Ligand Pharmaceuticals Ranks Among Analysts’ Top Picks With Strong Buyback Activity


A research of analyst suggestions on the main brokerages reveals that Ligand Pharmaceuticals Inc (Symbol: LGND) is the #11 dealer analyst choose amongst these shares screened by The Online Investor for sturdy stock buyback exercise. To make that checklist, a stock will need to have repurchased no less than 5% of its excellent shares over the trailing twelve month interval. In forming the rank, the analyst opinions from the key brokerage homes have been tallied, and averaged; then, the checklist of shares with sturdy buyback exercise was ranked in response to these averages.

LGND operates within the Biotechnology sector, amongst firms like Thermo Fisher Scientific Inc (TMO) which is down about 1.3% at this time, and Danaher Corp (DHR) buying and selling decrease by about 1.5%. Below is a 3 month worth historical past chart evaluating the stock efficiency of LGND, versus TMO and DHR.

LGND is presently buying and selling down about 0.5% noon Monday.

Top 25 Analyst Picks With Strong Stock Repurchase Activity »

The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.

Source link


Please enter your comment!
Please enter your name here